Stefanutti Giorgio, Pierro Agostino, Parkinson Emma J, Smith Virpi V, Eaton Simon
Department of Paediatric Surgery, Institute of Child Health, London, United Kingdom.
Crit Care Med. 2008 May;36(5):1564-72. doi: 10.1097/CCM.0b013e3181709e9f.
Moderate hypothermia is protective when applied throughout experimental intestinal ischemia and reperfusion (I/R). However, therapeutic intervention is usually possible only after ischemia has occurred. The aim of this study was to evaluate moderate hypothermia when applied at reperfusion as a rescue therapy for intestinal I/R.
Prospective, randomized, controlled experiment.
University research laboratory.
Adult male Sprague-Dawley rats (240-300 g).
In experiment I, rats underwent 60 mins of normothermic intestinal ischemia (36-38 degrees C) plus 300 mins of reperfusion at either normothermia or moderate hypothermia (30-32 degrees C) with or without rewarming. Hemodynamics were measured invasively and survival was assessed. In experiment II, rats underwent 60 mins of normothermic ischemia plus 120 mins of reperfusion at either normothermia or moderate hypothermia. At kill, organs and a blood sample were collected.
In experiment I, all normothermic I/R rats died within 197 mins of reperfusion after developing severe tachycardia and hypotension, whereas hypothermic rats, with or without rewarming, were alive at 300 mins of reperfusion (p < .001 vs. I/R normothermia) and were hemodynamically stable. In experiment II, normothermic reperfusion caused histologic and biochemical damage to the gut, hepatic energy failure, and inflammatory infiltration of the lung. However, hypothermia reduced injury to the reperfused ileum and prevented distant organ injury by counteracting energy failure in the liver, systemic overproduction of nitric oxide, altered cardiac fatty acid metabolism, and infiltration of inflammatory cells in the lungs.
Hypothermia applied as a rescue therapy for intestinal I/R abolishes mortality even after rewarming. Hypothermic protection during early reperfusion appears to be mediated by several pathways, including prevention of intestinal and pulmonary neutrophil infiltration, reduction of oxidative stress in the ileum, and preservation of cardiac and hepatic energy metabolism. Moderate hypothermia may improve outcome in clinical conditions associated with intestinal I/R.
在整个实验性肠缺血再灌注(I/R)过程中应用中度低温具有保护作用。然而,治疗干预通常只能在缺血发生后进行。本研究的目的是评估在再灌注时应用中度低温作为肠I/R的挽救治疗方法。
前瞻性、随机、对照实验。
大学研究实验室。
成年雄性Sprague-Dawley大鼠(240 - 300克)。
在实验I中,大鼠经历60分钟的常温肠缺血(36 - 38摄氏度),然后在常温或中度低温(30 - 32摄氏度)下进行300分钟的再灌注,有无复温。通过有创测量血流动力学并评估生存率。在实验II中,大鼠经历60分钟的常温缺血加120分钟的再灌注,分别在常温或中度低温下进行。处死时,收集器官和血样。
在实验I中,所有常温I/R大鼠在出现严重心动过速和低血压后,在再灌注197分钟内死亡,而低温大鼠,无论有无复温,在再灌注300分钟时仍存活(与常温I/R相比,p <.001),且血流动力学稳定。在实验II中,常温再灌注导致肠道组织学和生化损伤、肝脏能量衰竭以及肺部炎症浸润。然而,低温通过抵消肝脏能量衰竭、全身一氧化氮过度产生、心脏脂肪酸代谢改变以及肺部炎症细胞浸润,减轻了再灌注回肠的损伤并预防了远处器官损伤。
作为肠I/R的挽救治疗方法应用低温,即使复温后也可消除死亡率。早期再灌注期间的低温保护似乎由多种途径介导,包括预防肠道和肺部中性粒细胞浸润、减少回肠氧化应激以及维持心脏和肝脏能量代谢。中度低温可能改善与肠I/R相关临床情况的预后。